Haisco Pharmaceutical Group Co., Ltd. (002653.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 62.98

From 52W high−18.98%

Volume3.03M

Market capCNY 73.20B

P/E (TTM)282.0x

P/S (TTM)14.3x

Div yield1.25%

Key dataSep 18, 2026

Open

CNY 62.98

From 52W high

−18.98%

Volume

3.03M

Market cap

CNY 73.20B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

132.9x

P/E (TTM)

282.0x

RSI (14)

44.6

MomentumView details →

1D Return

−3.59%

YTD Return

+23.81%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

282.0x

EV/EBITDA

132.9x

EV/Sales

14.2x

P/S (TTM)

14.3x

P/B (TTM)

12.7x

ProfitabilityView details →

Gross Margin

74.48%

Net Margin

15.17%

EBITDA Margin

10.67%

ROE (TTM)

15.84%

ROA (TTM)

10.02%

Asset Turnover

0.69x

GrowthView details →

Revenue YoY

+31.04%

EPS YoY

+122.19%

FCF YoY

+2264.34%

Revenue CAGR 3Y

+13.32%

EPS CAGR 3Y

−4.00%

EBITDA YoY

—

MomentumView details →

1D Return

−3.59%

YTD Return

+23.81%

1Y Return

+17.56%

RSI (14)

44.6

vs 50D SMA

−5.08%

vs 200D SMA

+11.31%

Capital & dividendView details →

Debt/Equity

0.22x

Current Ratio

2.02x

Quick Ratio

1.81x

Div Yield

1.25%

Div Rate

CNY 0.79

Div Growth 1Y

+193.70%

EarningsView details →

EPS (Actual)

CNY 0.26

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

−1.19%

Financials snapshotView financials →

Revenue (TTM)

5.06B

Net Income (TTM)

767.58M

Op. CF (TTM)

1.12B

Next earningsNov 4, 2026 →

Latest newsMore news →

Haisco Pharmaceutical shareholder Fan Xiulian released a pledge of 2.36 million shares on September 7, 2026.12d ago

Haisco Pharmaceutical's controlling shareholder Wang Junmin extended the pledge of 9 million shares to China Merchants Securities, with the pledge maturity postponed to September 8, 2027.12d ago

Similar companies

恒逸石化000703.SZ 光库科技300620.SZ 广合科技001389.SZ 中信特钢000708.SZ 圣邦股份300661.SZ 鼎龙股份300054.SZ Find similar companies →

Latest newsMore news →

Haisco Pharmaceutical shareholder Fan Xiulian released a pledge of 2.36 million shares on September 7, 2026.12d ago Haisco Pharmaceutical's controlling shareholder Wang Junmin extended the pledge of 9 million shares to China Merchants Securities, with the pledge maturity postponed to September 8, 2027.12d ago Haisco licensed its preclinical immunology asset to Sentivera in a deal valued at more than $1.5 billion.25d ago